Categories AlphaGraphs, Earnings, Health Care
Infographic: Key highlights from Biogen (BIIB) Q2 2022 earnings results
Biogen Inc. (NASDAQ: BIIB) reported second quarter 2022 earnings results today.
Total revenue decreased 7% year-over-year to $2.58 billion.
Net income attributable to Biogen Inc. was $1 billion, or $7.24 per share, compared to $448.5 million, or $2.99 per share, last year. Adjusted EPS was $5.25.
Biogen raised its revenue and adjusted EPS guidance for the full year of 2022 based on better-than-expected topline performance and continued cost management. For FY2022, revenue is now expected to be $9.9-10.1 billion and adjusted EPS is now expected to be $15.25-16.75 compared to the previous ranges of $9.7-10 billion for revenue and $14.25-16.00 for adjusted EPS.
Prior performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Signet Jewelers (SIG) Q4 2025 Earnings fall on lower sales
Signet Jewelers Limited (NYSE: SIG) on Wednesday reported a decrease in adjusted earnings and net sales for the fourth quarter of 2025. Fourth-quarter sales declined 6% to $2.35 billion from
Paychex (PAYX) gears up for Q3 earnings with focus on business expansion
Paychex Inc. (NASDAQ: PAYX), a leading provider of human resources and payroll services, is expanding its artificial intelligence capabilities to stay relevant in the evolving HR landscape, while also increasing
What to look for when KB Home (KBH) reports Q1 2025 earnings results
Shares of KB Home (NYSE: KBH) dropped 1% on Tuesday. The stock has dropped 14% over the past three months. The homebuilder is slated to report its first quarter 2025
